Cover Image
Read Now

Ethical issues in studying the safety of approved drugs a letter report

The FDA requested that the IOM examine the ethical and informed consent issues that should be considered when conducting clinical trials to evaluate drug safety. This report outlines when and how the FDA should conduct clinical trials to protect the public's health and the health of trial parti...

Full description

Bibliographic Details
Corporate Author: Institute of Medicine (U.S.) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs
Format: eBook
Language:English
Published: Washington, D.C. National Academies Press 2010, [2010]
Subjects:
United States
Informed Consent / Ethics
Clinical Trials As Topic / Ethics
Product Surveillance, Postmarketing
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The FDA requested that the IOM examine the ethical and informed consent issues that should be considered when conducting clinical trials to evaluate drug safety. This report outlines when and how the FDA should conduct clinical trials to protect the public's health and the health of trial participants
Item Description:Title from PDF title page
Physical Description:1 PDF file (viii, 15 pages)

Similar Items